Yousif Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$754K Sell
4,811
-15,123
-76% -$2.27M 0.01% 1196
2026
Q1
$3.04M Sell
19,934
-2,780
-12% -$426K 0.04% 464
2025
Q4
$3.26M Sell
22,714
-3,095
-12% -$405K 0.04% 471
2025
Q3
$3.31M Sell
25,809
-3,145
-11% -$384K 0.04% 473
2025
Q2
$3.5M Buy
28,954
+1,429
+5% +$161K 0.04% 450
2025
Q1
$3.07M Sell
27,525
-6,280
-19% -$669K 0.04% 491
2024
Q4
$3.29M Hold
33,805
0.04% 475
2024
Q3
$3.89M Sell
33,805
-1,497
-4% -$170K 0.04% 416
2024
Q2
$3.76M Sell
35,302
-4,116
-10% -$413K 0.04% 421
2024
Q1
$3.81M Sell
39,418
-730
-2% -$74.8K 0.04% 461
2023
Q4
$4.05M Buy
40,148
+2,500
+7% +$241K 0.05% 408
2023
Q3
$3.83M Sell
37,648
-700
-2% -$71.1K 0.05% 396
2023
Q2
$3.87M Sell
38,348
-2,136
-5% -$214K 0.05% 412
2023
Q1
$3.72M Buy
40,484
+159
+0.4% +$13.9K 0.05% 416
2022
Q4
$3.66M Hold
40,325
0.05% 434
2022
Q3
$3.06M Hold
40,325
0.04% 464
2022
Q2
$3.41M Buy
40,325
+2,385
+6% +$209K 0.04% 460
2022
Q1
$3.33M Hold
37,940
0.04% 564
2021
Q4
$3.32M Buy
+37,940
New +$3.15M 0.03% 613

Other funds holding NVS

Yousif Capital Management's NVS Position: Q2 2026 in Review

Yousif Capital Management reduced its Novartis (NVS) stake by 76% in Q2 2026, selling an estimated $2.27M and leaving 4,811 shares worth $754K. The position accounts for 0.01% of the portfolio, ranked #1196.

Yousif Capital Management first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.05M in Q4 2023. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Yousif Capital Management held 4,811 shares of Novartis worth $754K as of Q2 2026.
  • Yousif Capital Management sold 15,123 Novartis shares in Q2 2026, an estimated $2.27M.
  • Novartis made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1196 holding.
  • Yousif Capital Management first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Novartis position peaked at $4.05M in Q4 2023.
  • 509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.